Table 2.
Estimation of drug content for physical mixture, solid dispersion prepared by kneading, and solvent evaporation method.
| Code | Ratios | Atorvastatin (mg) | Polymer (mg) | Drug content % |
|---|---|---|---|---|
| PM 1 | 1 : 1 | 20 | 20 | 95.98 ± 0.02 |
| PM 2 | 1 : 3 | 20 | 60 | 98.74 ± 0.13 |
| PM 3 | 1 : 6 | 20 | 120 | 100.01 ± 0.04 |
| PM 4 | 1 : 9 | 20 | 180 | 102.21 ± 0.1 |
| KM 1 | 1 : 1 | 20 | 20 | 98.85 ± 0.01 |
| KM 2 | 1 : 3 | 20 | 60 | 98.41 ± 0.17 |
| KM 3 | 1 : 6 | 20 | 120 | 100.47 ± 0.019 |
| KM 4 | 1 : 9 | 20 | 180 | 101 ± 0.124 |
| SE 1 | 1 : 1 | 20 | 20 | 98.35 ± 0.08 |
| SE 2 | 1 : 3 | 20 | 60 | 99.12 ± 0.4 |
| SE 3 | 1 : 6 | 20 | 120 | 100.81 ± 0.01 |
| SE 4 | 1 : 9 | 20 | 180 | 100.32 ± 0.06 |
n = 3; ATR: atorvastatin; PM: physical mixture; KM: kneading method; and SE: solvent evaporation method.